Cancer Companion Guide

Abstract Cancer remains a leading global cause of death, with incidence and mortality rates expected to rise in coming decades. While therapeutic advances have led to incremental survival gains, the most impactful strategy is prevention through modifiable risk factors. This article synthesizes current high-quality evidence and major guideline recommendations on diet, lifestyle, screenings, environmental exposures, and supplements to optimize cancer prevention strategies for clinicians, writers, and health-minded readers. 1. Introduction Despite trillions spent on cancer research  (The Lancet), cancer still kills around 10 million people a year  (WHO) and is a leading cause of death globally. The incidence of common cancers such as breast, lung, and colon cancer is expected to increase by over 75% between 2022 and 2050.   Credit:  Statista Ladanie et al (JAMA 2020) showed that over the past fifteen years, new therapies have led to an overall survival improvement of...

Abstract Cancer remains a leading cause of mortality worldwide, with incidence rates projected to rise significantly in the coming decades. While advances in treatment have modestly improved survival, prevention through modifiable risk factors remains underemphasized. This review synthesizes current evidence on the role of diet, lifestyle, and dietary supplements in cancer prevention, drawing on systematic reviews, meta-analyses, and major guideline recommendations. The I-PREVENT CANCER protocol is introduced as a practical, evidence-based framework for reducing cancer risk. Introduction Despite trillions spent on cancer research , cancer still kills around 10 million people a year and is a leading cause of death globally. The incidence of common cancers such as breast, lung, and colon cancer is expected to increase by over 75% between 2022 and 2050.  While treatment advances offer incremental improvements in survival, prevention strategies—particularly those related to diet and l...

Key message: Lifestyle interventions do not replace immunotherapy — but they can meaningfully influence who responds, how well, and how long responses last by shaping metabolism, inflammation, and immune fitness. Why Lifestyle Matters in the Era of Immunotherapy Immune checkpoint inhibitors (PD-1, PD-L1, CTLA-4) have transformed cancer care, yet: Only 20–40% of patients achieve durable responses Many experience immune-related adverse events Metabolic and inflammatory status strongly influence outcomes Lifestyle factors act upstream of the immune system, affecting T-cell energetics, cytokine balance, gut microbiota, and systemic inflammation — all critical to immunotherapy success. Metabolic Health: The Primary Modifier of Immune Response Insulin Resistance and Hyperglycemia Poor glycemic control is associated with: Impaired T-cell activation Increased regulatory T-cell dominance Reduced response rates to checkpoint inhibitors Conversely, improved insulin sensitivity supports: CD8+ T-...

Diet and lifestyle matter for risk reduction and treatment resilience , but they are not standalone cancer therapies. Modern evidence points to metabolism, inflammation, and immune function as the real intermediaries between lifestyle and cancer outcomes. Since this article was first published in 2025, cancer research has moved decisively beyond simplistic claims like “food cures cancer” or “lifestyle alone prevents malignancy.” Large cohort studies, metabolic research, and clinical oncology data now paint a more nuanced picture: Diet influences metabolic signaling , not tumors directly Lifestyle changes lower cancer incidence risk , but rarely eliminate it Outcomes improve most when lifestyle is combined with evidence-based therapy This update reflects current consensus while addressing persistent myths. AACR Cancer Progress Report 2023 / 2024 Diet and Cancer: Association vs Causation What Diet Can Do Strong evidence shows that diet affects: Obesity and insulin resistance Chronic...